Time to see who blinks first on PDUFA

Washington

WASHINGTON - Reauthorization of the Prescription Drug User Fee Act and FDA reform legislation (S. 830) will be near the top of a very full agenda when the Senate resumes its work this week. But the Senators will be asked to vote on a revised version of S. 830 that many of them still have not seen, and the prospect of last-minute roadblocks erected by Sen. Edward Kennedy continues to haunt efforts to link reform provisions with PDUFA, which exipires at the end of the month.

The current version of S. 830 reflects negotiations between Republicans on the Labor and Human Resources Committee and Kennedy

Read the full 1061 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE